- Abstract Number: 1609
Lack of Association Between ZHX2, Lepr, Gckr and ASCL1 and Carotid Intima-Media Thickness, Carotid Plaques and Cardiovascular Disease in Patients with Rheumatoid Arthritis
- Abstract Number: 1952
Lack of Association of a 6.7 Kbp Deletion of LILRA3 with Giant Cell Arteritis
- Abstract Number: 1659
Lack of Effect of Reduced Folic Acid Supplementation on Disease Activity in RA
- Abstract Number: 1615
Lack of Replication of the Association Between Anti-Citrullinated Fibrinogen and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
- Abstract Number: 336
Lack of Uniform Diagnostic Criteria for Erosive OA: A Systematic Review
- Abstract Number: 1991
Large Vessel Involvement By IgG4-Related Disease
- Abstract Number: 2979
Laser Speckled Imaging and Videomicroscopy Assessment of Sublingual Perfusion in Systemic Sclerosis and Healthy Controls
- Abstract Number: 733
Late Onset Systemic Lupus Erythematosus: A Different Disease Subset?
- Abstract Number: 894
Late-Onset IgA Vasculitis in Adult Patients Exhibits Distinct Clinical Characteristics and Outcomes
- Abstract Number: 2903
Late-Onset Neutropenia Following Rituximab Treatment in Patients with Systemic Lupus Erythematosus
- Abstract Number: 2790
Leflunomide/Hydroxychoroquine Combination Treatment Additively Inhibits T Cell Receptor/Toll-like Receptor 9-Triggered Th1 and Th17 Cytokine Secretion
- Abstract Number: 1821
Leptin, Adiponectin, and Resistin As Serum Markers of Fatigue in Systemic Lupus Erythematosus: A Pilot Study
- Abstract Number: 2353
Lesinurad and Febuxostat Combination Therapy: Analysis of Treatment Based on Patient Baseline Renal Function
- Abstract Number: 2113
Lesinurad, a Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout
- Abstract Number: 2596
Less Musculoskeletal Ultrasound Power Doppler Activity Seen in Obese Rheumatoid Arthritis
- Abstract Number: 1085
Levamisole Triggers Neutrophil Extracellular Trap Formation through Muscarinic Receptors in Patients with Drug-Induced Vasculitis
- Abstract Number: 334
Lifetime Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project
- Abstract Number: 135
Limitations of Treat-to-Target in Rheumatoid Arthritis: Joint Damage Appears As Severe As Inflammation in Contemporary Care at One Site
- Abstract Number: 1508
Lipid Target Achievement Among Patients with Recent-Onset Rheumatoid Arthritis during the First Six Years of Follow-up: Results from a French Multicenter Cohort of Early Arthritis
- Abstract Number: 1788
Lipoprotein Subfractions and Cardiovascular Disease in Systemic Lupus Erythematosus
- Abstract Number: 2336
Literature Review of Patient Reported Outcome and Health Related Quality of Life Measures for Biologic Therapies in the Management of Psoriatic Arthritis and Ankylosing Spondylitis
- Abstract Number: 2152
Long Noncoding H19X Is a Key Mediator of Tgf-Beta Induced Pro-Fibrotic Effects in the Pathogenesis of Systemic Sclerosis and Other Fibrotic Diseases
- Abstract Number: 3041
Long Term Biological Therapy in Uveitis Refractory Due to Behçet’s Disease. Multicenter Study of 165 Patients.
- Abstract Number: 2049
Long Term Effectiveness of Herpes Zoster Vaccine Among Patients with Autoimmune and Inflammatory Diseases
- Abstract Number: 406
Long Term Follow up of Inner City Pediatric Patients with Lupus Nephritis
- Abstract Number: 3069
Long Term Follow-up Results of Endovascular Repair in the Management of Arterial Stenosis Caused By Takayasu Arteritis
- Abstract Number: 1396
Long Term Outcome of Neurosarcoidosis
- Abstract Number: 2195
Long Term Outcome of Primary Antiphospholipid Syndrome Patients: A Multicenter Study
- Abstract Number: 1701
Long Term Outcome of Total Hip Replacement in Patients with Ankylosing Spondylitis
- Abstract Number: 2840
Long-Term (104 Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
- Abstract Number: 2843
Long-Term (156-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)
- Abstract Number: 619
Long-Term Adverse Events after Daily Concomitant Treatment with 10mg Prednisone in the 2-Year Computer Assisted Management in Early Rheumatoid Arthritis Trial-II
- Abstract Number: 1446
Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry
- Abstract Number: 2885
Long-Term Effects of Etanercept on Patient-Reported Outcomes in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Results of a Phase III Study
- Abstract Number: 939
Long-Term Efficacy and Safety of Canakinumab in Active Hyperimmunoglobulinemia D with Periodic Fever Syndrome
- Abstract Number: 938
Long-Term Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF Receptor-Associated Periodic Syndrome
- Abstract Number: 2427
Long-Term Efficacy and Safety of Mycophenolate Mofetil in Childhood Primary Central Nervous System Vasculitis
- Abstract Number: 1351
Long-Term Efficacy of Latent Tuberculosis Infection Screening in Juvenile Idiopathic Arthritis Patients Prior to Anti-TNF Treatment in an Endemic Area
- Abstract Number: 596
Long-Term High Remission Rates and Distinct Trajectories of Disease Activity Following the Implementation of Treat-to-Target in Early Rheumatoid Arthritis
- Abstract Number: 2835
Long-Term Improvements with Certolizumab Pegol in Joints and Extra-Articular Manifestations of Psoriatic Arthritis in Patients with and without Prior Anti-TNF Exposure
- Abstract Number: 276
Long-Term Outcome in Mixed Connective Tissue Disease
- Abstract Number: 1816
Long-Term Outcome of Tacrolimus Therapy As a Maintenance Strategy in Patients with Lupus Nephritis
- Abstract Number: 2046
Long-Term Outcomes in Cardiac Neonatal Lupus and Associated Risk Factors for Morbidity
- Abstract Number: 404
Long-Term Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus
- Abstract Number: 780
Long-Term Prognosis and Factors Associated with Damage Accrual in Japanese Patients with Systemic Lupus Erythematosus
- Abstract Number: 1633
Long-Term Radiographic and Patient-Reported Outcomes Based on Clinical Disease Activity Index Responses with Tofacitinib at 6 Months
- Abstract Number: 2765
Long-Term Retention Rate of First Biologics in Patients of Age over 75 Years with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
- Abstract Number: 3111
Long-term Safety and Efficacy of Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-α (GM–CSFR-α) Monoclonal Antibody, in Patients with Rheumatoid Arthritis (RA)
- Abstract Number: 1649
Long-Term Safety and Efficacy of Olokizumab in Patients with Moderate-to-Severe Rheumatoid Arthritis Who Have Previously Failed Anti-TNF Treatment
- Abstract Number: 1795
Long-Term Safety and Efficacy of Tacrolimus for Lupus Nephritis Patients in Real World Setting -Results from 5 Year Interim Analysis of Post Marketing Surveillance of 1376 Patients in Japan-
- Abstract Number: 2431
Long-Term Safety of Adalimumab Treatment in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis and Enthesitis-Related Arthritis
- Abstract Number: 2759
Long-Term Survival of Biological Therapy in Rheumatoid Arthritis Elderly Patients in Clinical Practice
- Abstract Number: 1977
Long-Term Survival of Methotrexate in Giant Cell Arteritis Patients in Clinical Practice
- Abstract Number: 2854
Long-Term Tolerability and Efficacy of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results from the Open-Label Extension of a Randomized, Double-Blind Study
- Abstract Number: 1225
Long-Term Use of Biological Therapy and Discontinuation Rates in Rheumatoid Arthritis – Real World Patient Data
- Abstract Number: 891
Long-Term Use of Rituximab for Eosinophilic Granulomatosis with Polyangiitis
- Abstract Number: 2864
Long-Term Work Productivity Improvement Associated with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Analysis of 3 Phase 3 Studies
- Abstract Number: 2942
Longitudinal Analyses of Progression of Brain Athrophy in Childhood-Onset Systemic Lupus Erythematosus
- Abstract Number: 2978
Longitudinal Assessment of Gastrointestinal Symptoms in the Prospective Registry of Early Systemic Sclerosis Cohort
- Abstract Number: 744
Longitudinal Assessment of Th1 and Th2 Cytokines: A Comparison Between Adult-Onset and Childhood-Onset Systemic Lupus Erythematous
- Abstract Number: 397
Longitudinal Observation of Psychological Factors and Health-Related Quality of Life in Childhood-Onset Lupus
- Abstract Number: 113
Longitudinal, Incremental Direct Medical Costs of Giant Cell Arteritis for the First Five Years Following Diagnosis: A General Population-Based Cohort Study
- Abstract Number: 2524
Longterm Follow-up of Children Born to Mothers with Chronic Arthritides and Exposed to Anti-TNF Alfa Agents during Pregancy and Breastfeeding: A Case-Control Study
- Abstract Number: 2774
Longterm Outcome of Patients Switched from Iv to Sc Formulation of Abatacept: A Monocentric Study
- Abstract Number: 2203
Loss of Wdfy3 Leads to Enhanced Osteoclastogenesis Via NF-κB Activation
- Abstract Number: 352
Low Bone Density Is Associated with Atherosclerotic Disease in Patients with Psoriatic Arthritis
- Abstract Number: 2068
Low Complement Is Associated with SLE Classification Criteria and Organ Damage
- Abstract Number: 446
Low Disease Activity at 12 Weeks and 24 Weeks Is Predictive of Normalized Health-Related Quality of Life in Methotrexate-Experienced Patients with Active Rheumatoid Arthritis Treated with Intravenous Golimumab Plus Methotrexate
- Abstract Number: 2658
Low Disease Activity Is Associated with Higher HDL and a Trend to Lower Insulin Resistance in Rheumatoid Arthritis Patients
- Abstract Number: 2169
Low Education Is Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project
- Abstract Number: 1137
Low Molecular Weight Polyphenol Harpagoside Inhibits IL-1β-Induced Expression of IL-6 By Blocking the Expression and Activity of c-Fos in Primary Human Osteoarthritis Chondrocytes
- Abstract Number: 2933
Low Prevalence of PCP in Hospitalized Patients with SLE: Review of a Clinical Database Warehouse
- Abstract Number: 1270
Low Socioeconomic Status As a Predictor of Long-Term Direct Medical Costs Following Diagnosis of Granulomatosus with Polyangiitis: A General Population-Based Cohort Study
- Abstract Number: 85
Low Socioeconomic Status, High Disability Rates, and Increased Use of Health Care Resources in Fibromyalgia Patients Taking Narcotics
- Abstract Number: 882
Lung Damage in ANCA Associated Vasculitis Assessed By Vasculitis Damage Index: Recurrent Pulmonary Infections Have a Significant Contribution
- Abstract Number: 814
Lupus Drives Atherosclerosis through CD4+CXCR3+ T Cells and Plasmacytoid Dendritic Cells
- Abstract Number: 2921
Lupus Nephritis: An Exploration of Management Style
- Abstract Number: 763
Lupus-Related SNPs and Risk of Diffuse Large B-Cell Non-Hodgkin Lymphoma
- Abstract Number: 1777
Lymphocyte Depletion, Recovery and Efficacy in NZBWF1 Lupus Mice Following Continuous or Intermittent Dosing Regimen of Venetoclax (ABT-199), a Potent and Selective BCL-2 Inhibitor
- Abstract Number: 869
Lymphoma in Patients with Granulomatosis with Polyangiitis
- Abstract Number: 2052
Lymphoma in Patients with Rheumatoid Arthritis Treated with Biologic Drugs: Long-Term Follow-up of Risks and Lymphoma Subtypes
- Abstract Number: 815
Lys63-Polyubiquitination By the E3 Ligase Casitas B-Lineage Lymphoma-b Modulates Peripheral Regulatory T Cell Tolerance in Patients with Systemic Lupus Erythematosus
- Abstract Number: 1913
Lysyl Oxidase Induces Fibrosis Via Upregulation of IL-6 and Serves As a Biomarker to Monitor Response to Therapy
2015 ACR/ARHP Annual Meeting
November 6-11, 2015 in San Francisco, CA